Philippines Government Slaps Price Caps On Innovative Drugs; Pfizer Reacts With Disappointment
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - After pressuring international pharmaceutical companies to drastically reduce prices on a list of basic drugs, with mixed results, the Philippines government is imposing price caps by executive order in a move that will take effect August 15
You may also be interested in...
Philippines Plans A New Round Of Drug Price Cuts For Branded Products
SHANGHAI - The Philippines' Department of Health is mapping out plans for yet another round of drug price cuts following those imposed in mid-2009 and in early 2010
Philippines Plans A New Round Of Drug Price Cuts For Branded Products
SHANGHAI - The Philippines' Department of Health is mapping out plans for yet another round of drug price cuts following those imposed in mid-2009 and in early 2010
South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig
To ramp up pharmaceutical sales, the company may have to overcome some considerable challenges directly linked to the country's increasingly indebted health care system.